Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
about
Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal CancerAssociation between factors associated with colorectal cancer and rectal aberrant crypt foci in humans.Accumulation of aberrant DNA methylation during colorectal cancer development.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.Ethanolic Extract of Bark from Salix aegyptiaca Ameliorates 1,2-dimethylhydrazine-induced Colon Carcinogenesis in Mice by Reducing Oxidative Stress.
P2860
Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Eicosapentaenoic acid (EPA) ef ...... nd randomized controlled trial
@ast
Eicosapentaenoic acid (EPA) ef ...... nd randomized controlled trial
@en
type
label
Eicosapentaenoic acid (EPA) ef ...... nd randomized controlled trial
@ast
Eicosapentaenoic acid (EPA) ef ...... nd randomized controlled trial
@en
prefLabel
Eicosapentaenoic acid (EPA) ef ...... nd randomized controlled trial
@ast
Eicosapentaenoic acid (EPA) ef ...... nd randomized controlled trial
@en
P2093
P2860
P356
P1433
P1476
Eicosapentaenoic acid (EPA) ef ...... nd randomized controlled trial
@en
P2093
Akiko Ezuka
Atsushi Nakajima
Eiji Sakai
Eiji Yamada
Hajime Nagase
Hidenori Ohkubo
Hirokazu Takahashi
Hiroki Endo
Hiroshi Iida
Kunihiro Hosono
P2860
P2888
P356
10.1186/1471-2407-12-413
P407
P577
2012-09-19T00:00:00Z
P5875
P6179
1024857900